Wisdom Pharmaceutical is an API manufacturer based in China. It holds 35 active US drug master files across a filed portfolio of 29 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3004486763 |
| Molecule | Regulators | Docs |
|---|---|---|
| Ibrutinib | US FDA | 3 |
| Alogliptin | US FDA | 2 |
| Aprepitant | US FDA | 2 |
| Dronedarone | US FDA | 2 |
| Entecavir | US FDA | 2 |
| Axitinib | US FDA | 1 |
| Baricitinib | US FDA | 1 |
| Benazepril | US FDA | 1 |
| Bendamustine | US FDA | 1 |
| Carfilzomib | US FDA | 1 |
| Dapagliflozin | US FDA | 1 |
| Difelikefalin | US FDA | 1 |
| Eribulin | US FDA | 1 |
| Exatecan | US FDA | 1 |
| Fasudil | US FDA | 1 |
| Flupirtine | US FDA | 1 |
| Fondaparinux | US FDA | 1 |
| Fosaprepitant | US FDA | 1 |
| Fulvestrant | US FDA | 1 |
| Gefitinib | US FDA | 1 |
| Iron | US FDA | 1 |
| Lacosamide | US FDA | 1 |
| Lamivudine | US FDA | 1 |
| Linagliptin | US FDA | 1 |
| Lurbinectedin | US FDA | 1 |
| Mefenamic Acid | US FDA | 1 |
| Olaparib | US FDA | 1 |
| Sacubitril | US FDA | 1 |
| Tirofiban | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Choose your molecules and target markets. Wisdom Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free